TipRanks
Advertisement
Advertisement

SPRO Stock Latest News

Spero Therapeutics price target raised to $6 from $5 at H.C. Wainwright
The FlySpero Therapeutics price target raised to $6 from $5 at H.C. Wainwright
6d ago
SPRO
Spero Therapeutics Launches New Jefferies ATM Equity Program
PremiumCompany Announcements
Spero Therapeutics Launches New Jefferies ATM Equity Program
23d ago
8K
SPRO
Spero Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Spero Therapeutics files $300M mixed securities shelf
23d ago
SPRO
Spero Therapeutics Earnings Call Signals High‑Risk Pivot
PremiumCompany Announcements
Spero Therapeutics Earnings Call Signals High‑Risk Pivot
1M ago
SPRO
Spero Therapeutics appoints Debra Jeske Zack as chief medical officer
PremiumThe Fly
Spero Therapeutics appoints Debra Jeske Zack as chief medical officer
2M ago
XGN
SPRO
Spero Therapeutics inks major CD40L and royalty deals
PremiumCompany AnnouncementsSpero Therapeutics inks major CD40L and royalty deals
2M ago
8K
SPRO
Spero Therapeutics secures $105M non-dilutive financing to develop SP001
Premium
The Fly
Spero Therapeutics secures $105M non-dilutive financing to develop SP001
2M ago
SPRO
Spero Therapeutics, Innovent Biologics enter license agreement for SP001
Premium
The Fly
Spero Therapeutics, Innovent Biologics enter license agreement for SP001
2M ago
SPRO
Spero Therapeutics, Innovent Biologics announce exclusive IBI355 license pact
PremiumThe Fly
Spero Therapeutics, Innovent Biologics announce exclusive IBI355 license pact
2M ago
SPRO
Spero Therapeutics Expands Stock Incentive Plan and Authorization
PremiumCompany Announcements
Spero Therapeutics Expands Stock Incentive Plan and Authorization
3M ago
8K
SPRO
Spero Therapeutics secures FDA approval for Utebzi
PremiumCompany Announcements
Spero Therapeutics secures FDA approval for Utebzi
3M ago
8K
SPRO
GSK, Spero Therapeutics announce FDA approval of Utebzi
PremiumThe Fly
GSK, Spero Therapeutics announce FDA approval of Utebzi
3M ago
GSK
SPRO
Spero Therapeutics Co-Founder Resigns From Board Roles
PremiumCompany AnnouncementsSpero Therapeutics Co-Founder Resigns From Board Roles
8M ago
8K
SPRO
GSK Resubmits NDA, Triggering Milestone for Spero Therapeutics
Premium
Company Announcements
GSK Resubmits NDA, Triggering Milestone for Spero Therapeutics
9M ago
8K
SPRO
Spero announces GSK filed NDA resubmission to FDA for tebipenem HBr
Premium
The Fly
Spero announces GSK filed NDA resubmission to FDA for tebipenem HBr
9M ago
GSK
SPRO
Spero Therapeutics announces inducement grant under Nasdaq listing rule
PremiumThe Fly
Spero Therapeutics announces inducement grant under Nasdaq listing rule
10M ago
SPRO
Spero Therapeutics Focuses on Tebipenem HBr Program
PremiumCompany Announcements
Spero Therapeutics Focuses on Tebipenem HBr Program
10M ago
SPRO
Spero Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Spero Therapeutics Reports Q3 2025 Financial Results
10M ago
8K
SPRO
Spero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
PremiumThe Fly
Spero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
11M ago
GSK
SPRO
Spero Therapeutics’ Positive Earnings Call Highlights
PremiumCompany AnnouncementsSpero Therapeutics’ Positive Earnings Call Highlights
1y ago
SPRO
Spero Therapeutics Reports Q2 2025 Results and Trial Success
Premium
Company Announcements
Spero Therapeutics Reports Q2 2025 Results and Trial Success
1y ago
SPRO
Spero Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Spero Therapeutics Reports Q2 2025 Financial Results
1y ago
8K
SPRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >